Stock comparison
Harmony Biosciences Holdings
HRMY$1.98BHealthcare Market cap, Sector
JEENA SIKHO LIFECARE
JSLL.NS$72.75BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
HRMY 07 JSLL.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
HRMY0wins
7winsJSLL.NS
67C
B84
61C
A87
75B
A92
62C
C66
28F
B75
62C
A91
67C
A95
Side-by-side metrics
| Metric | HRMY | JSLL.NS |
|---|---|---|
| Market cap | $1.98B | $72.75B Winner |
| P/E (TTM) | Winner: 12.5x | 33.3x |
| EV/EBIT | Winner: 6.9x | 24.1x |
| ROIC (TTM) | 12.5% | 39.15% Winner |
| Gross margin | 76.55% | 88.58% Winner |
| Net margin | 16.2% | 27.68% Winner |
| Revenue CAGR 5y | 29.85% | 57.81% Winner |
| EPS CAGR 5y | 46.45% | 86.67% Winner |
| Debt / Equity | Winner: 0.2x | 0.3x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HRMY leads on
- EV/EBIT6.9xvs 24.1x+71%
- P/E (TTM)12.5xvs 33.3x+62%
- Debt / Equity0.2xvs 0.3x+17%
JSLL.NS leads on
- Market cap$72.75Bvs $1.98B+97%
- ROIC (TTM)39.15%vs 12.5%+68%
- Revenue CAGR 5y57.81%vs 29.85%+48%
- EPS CAGR 5y86.67%vs 46.45%+46%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.